| - GRCh37:
- Chr2:155150555-176854100
- GRCh38:
- Chr2:154294042-175989372
| SLC25A12, SLC38A11, SPC25, SLC4A10, SNORA70F, SNORD3K, SP3, SP5, SP9, SSB, STK39, TANC1, TANK, TANK-AS1, TBR1, TLK1, TRA-CGC3-1, TRG-GCC2-2, TTC21B, TTC21B-AS1, UBR3, UPP2, WDSUB1, WIPF1, XIRP2, XIRP2-AS1, ABCB11, ACVR1, ACVR1C, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BAZ2B, BAZ2B-AS1, BBS5, CCDC148, CCDC148-AS1, CD302, CDCA7, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CIR1, COBLL1, CSRNP3, CYBRD1, CYTIP, DAPL1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DPP4, DPP4-DT, DYNC1I2, ERICH2, ERICH2-DT, ERMN, FAP, FASTKD1, FIGN, FLJ46875, G6PC2, GAD1, GALNT13, GALNT13-AS1, GALNT3, GALNT5, GCA, GCG, GORASP2, GPD2, GPR155, GPR155-DT, GRB14, HAT1, IFIH1, ITGA6, ITGA6-AS1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KLHL23, KLHL41, LINC01124, LINC01305, LINC01806, LINC01876, LINC01960, LINC02478, LNPK, LOC100506124, LOC101929532, LOC101929633, LOC102724058, LOC108175345, LOC108281133, LOC110120601, LOC110120624, LOC110120625, LOC110120626, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120677, LOC110120678, LOC110120701, LOC110120708, LOC110120710, LOC110120725, LOC110120730, LOC110120736, LOC110120790, LOC110120809, LOC110121120, LOC110121216, LOC110121242, LOC111413009, LOC111556122, LOC112806056, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC114827830, LOC115945201, LOC117152610, LOC117152611, LOC120977010, LOC120977011, LOC120977012, LOC120977013, LOC120977014, LOC120977015, LOC121725105, LOC121725106, LOC121725107, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LOC126806394, LOC126806395, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LRP2, LY75, LY75-CD302, MAP3K20, MAP3K20-AS1, MARCHF7, METAP1D, METTL5, METTL8, MIR4774, MIR4785, MIR6888, MIR933, MYO3B, MYO3B-AS1, NOSTRIN, NR4A2, OLA1, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PKP4, PKP4-AS1, PLA2R1, PPIG, PSMD14, PSMD14-DT, RAPGEF4, RAPGEF4-AS1, RBMS1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3 | | See cases | Pathogenic (Mar 10, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:164821892-183059789
- GRCh38:
- Chr2:163965382-182195062
| ABCB11, AGPS, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BBS5, CCDC141, CDCA7, CERKL, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CHROMR, CIR1, COBLL1, CSRNP3, CWC22, CYBRD1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DYNC1I2, EPCART, ERICH2, ERICH2-DT, EVX2, FASTKD1, FKBP7, G6PC2, GAD1, GALNT3, GORASP2, GPR155, GPR155-DT, GRB14, HAGLR, HAGLROS, HAT1, HNRNPA3, HOXD-AS2, HOXD1, HOXD10, HOXD11, HOXD12, HOXD13, HOXD3, HOXD4, HOXD8, HOXD9, IFT70A, IFT70B, ITGA4, ITGA6, ITGA6-AS1, ITPRID2, KLHL23, KLHL41, LINC01116, LINC01117, LINC01124, LINC01305, LINC01934, LINC01960, LNPK, LOC100130691, LOC100506124, LOC101927055, LOC101929633, LOC102724058, LOC105373759, LOC107126359, LOC108281145, LOC110120624, LOC110120625, LOC110120626, LOC110120627, LOC110120628, LOC110120677, LOC110120678, LOC110120701, LOC110120730, LOC110120790, LOC110120809, LOC110121216, LOC111413009, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC112806061, LOC112806062, LOC112806063, LOC115945201, LOC120977013, LOC120977014, LOC120977015, LOC120977016, LOC121725107, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC122861247, LOC122861248, LOC122861249, LOC122861250, LOC122861251, LOC122861252, LOC122861253, LOC122861254, LOC122861255, LOC122861256, LOC122861257, LOC122861258, LOC122861259, LOC122861260, LOC122861261, LOC122861262, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LOC126806413, LOC126806414, LOC126806415, LOC126806416, LOC126806417, LOC126806418, LOC126806419, LOC126806420, LOC126806421, LOC126806422, LOC126806423, LOC126806424, LOC126806425, LOC126806426, LOC126806427, LOC126806428, LOC126806429, LOC126806430, LOC126806431, LOC126806432, LOC126806433, LOC126806434, LOC126806435, LOC126806436, LOC126806437, LOC126806438, LOC126806439, LOC126806440, LOC126806441, LOC401021, LRP2, MAP3K20, MAP3K20-AS1, METAP1D, METTL5, METTL8, MIR10B, MIR1246, MIR1258, MIR3128, MIR4437, MIR4444-1, MIR4774, MIR6512, MIR7704, MIR933, MTX2, MYO3B, MYO3B-AS1, NEUROD1, NFE2L2, NOSTRIN, OLA1, OSBPL6, PDE11A, PDE11A-AS1, PDE1A, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PJVK, PLEKHA3, PPIG, PPP1R1C, PRKRA, RAPGEF4, RAPGEF4-AS1, RBM45, SCHLAP1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3, SESTD1, SLC25A12, SLC38A11, SNORA70F, SNORD3K, SP3, SP5, SP9, SPC25, SSB, STK39, TLK1, TTC21B, TTC21B-AS1, TTN, TTN-AS1, UBE2E3, UBE2E3-DT, UBR3, WIPF1, XIRP2, XIRP2-AS1, ZNF385B | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:164922548-172962614
- GRCh38:
- Chr2:164066038-172097886
| ABCB11, B3GALT1, B3GALT1-AS1, BBS5, CERS6, CERS6-AS1, CFAP210, COBLL1, CSRNP3, CYBRD1, DCAF17, DHRS9, DLX1, DYNC1I2, ERICH2, ERICH2-DT, FASTKD1, G6PC2, GAD1, GALNT3, GORASP2, GRB14, HAT1, KLHL23, KLHL41, LINC01124, LOC100506124, LOC101929633, LOC102724058, LOC110120678, LOC110120701, LOC110120730, LOC110121216, LOC111413009, LOC112806057, LOC112806058, LOC115945201, LOC120977013, LOC120977014, LOC121725107, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LRP2, METAP1D, METTL5, METTL8, MIR4774, MYO3B, MYO3B-AS1, NOSTRIN, PHOSPHO2, PHOSPHO2-KLHL23, PPIG, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SLC25A12, SLC38A11, SNORA70F, SNORD3K, SP5, SPC25, SSB, STK39, TLK1, TTC21B, TTC21B-AS1, UBR3, XIRP2, XIRP2-AS1 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:165706627-176423918
- GRCh38:
- Chr2:164850117-175559190
| ABCB11, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BBS5, CDCA7, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CIR1, CSRNP3, CYBRD1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DYNC1I2, ERICH2, ERICH2-DT, FASTKD1, G6PC2, GAD1, GALNT3, GORASP2, GPR155, GPR155-DT, HAT1, ITGA6, ITGA6-AS1, KLHL23, KLHL41, LINC01124, LINC01305, LINC01960, LOC100506124, LOC102724058, LOC110120624, LOC110120625, LOC110120626, LOC110120678, LOC110120701, LOC110120730, LOC110120790, LOC110120809, LOC110121216, LOC112806058, LOC112806059, LOC112806060, LOC115945201, LOC120977013, LOC120977014, LOC120977015, LOC121725107, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LRP2, MAP3K20, MAP3K20-AS1, METAP1D, METTL5, METTL8, MIR4774, MIR933, MYO3B, MYO3B-AS1, NOSTRIN, OLA1, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PPIG, RAPGEF4, RAPGEF4-AS1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3, SLC25A12, SLC38A11, SNORD3K, SP3, SP5, SP9, SPC25, SSB, STK39, TLK1, TTC21B, TTC21B-AS1, UBR3, WIPF1, XIRP2, XIRP2-AS1 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169740860-170815789
- GRCh38:
- Chr2:168884350-169959279
| ABCB11, BBS5, CFAP210, DHRS9, FASTKD1, G6PC2, KLHL23, KLHL41, LOC120977014, LOC122847310, LOC126806400, LOC126806401, LRP2, METTL5, PHOSPHO2, PHOSPHO2-KLHL23, PPIG, SNORD3K, SPC25, SSB, UBR3 | | See cases | Uncertain significance (Oct 24, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr2:169779462
- GRCh38:
- Chr2:168922952
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779492
- GRCh38:
- Chr2:168922982
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779599
- GRCh38:
- Chr2:168923089
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779623
- GRCh38:
- Chr2:168923113
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779692
- GRCh38:
- Chr2:168923182
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779712
- GRCh38:
- Chr2:168923202
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779726
- GRCh38:
- Chr2:168923216
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779764
- GRCh38:
- Chr2:168923254
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779816
- GRCh38:
- Chr2:168923306
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779851
- GRCh38:
- Chr2:168923341
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779880
- GRCh38:
- Chr2:168923370
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779895
- GRCh38:
- Chr2:168923385
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169779896
- GRCh38:
- Chr2:168923386
| ABCB11 | | not provided, Progressive familial intrahepatic cholestasis type 2 | Benign (Jun 29, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:169779939
- GRCh38:
- Chr2:168923429
| ABCB11 | | Progressive familial intrahepatic cholestasis | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780106
- GRCh38:
- Chr2:168923596
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780126
- GRCh38:
- Chr2:168923616
| ABCB11 | | not specified | Likely benign (Feb 10, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780136
- GRCh38:
- Chr2:168923626
| ABCB11 | S1321T | not provided | Uncertain significance (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780136
- GRCh38:
- Chr2:168923626
| ABCB11 | S1321N | not provided, Progressive familial intrahepatic cholestasis type 2 | Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:169780141
- GRCh38:
- Chr2:168923631
| ABCB11 | | not provided | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780147
- GRCh38:
- Chr2:168923637
| ABCB11 | | not provided | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780152
- GRCh38:
- Chr2:168923642
| ABCB11 | T1316A | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:169780153
- GRCh38:
- Chr2:168923643
| ABCB11 | T1316fs | not provided | Uncertain significance (Feb 25, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780161
- GRCh38:
- Chr2:168923651
| ABCB11 | | not provided | Likely benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780171
- GRCh38:
- Chr2:168923661
| ABCB11 | | not provided | Likely benign (Aug 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780175
- GRCh38:
- Chr2:168923665
| ABCB11 | G1308fs | not provided | Uncertain significance (Oct 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780177
- GRCh38:
- Chr2:168923667
| ABCB11 | | not provided | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780181
- GRCh38:
- Chr2:168923671
| ABCB11 | Q1306R | not provided | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780183
- GRCh38:
- Chr2:168923673
| ABCB11 | | not provided | Likely benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780192
- GRCh38:
- Chr2:168923682
| ABCB11 | | not provided | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780194
- GRCh38:
- Chr2:168923684
| ABCB11 | E1302* | not provided | Pathogenic (Jul 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780195
- GRCh38:
- Chr2:168923685
| ABCB11 | | not provided | Likely benign (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780204
- GRCh38:
- Chr2:168923694
| ABCB11 | | not provided | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780207-169780208
- GRCh38:
- Chr2:168923697-168923698
| ABCB11 | T1299fs | not provided | Pathogenic (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780223
- GRCh38:
- Chr2:168923713
| ABCB11 | G1292E | Benign recurrent intrahepatic cholestasis type 2 | Likely pathogenic (Sep 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780223
- GRCh38:
- Chr2:168923713
| ABCB11 | G1292V | not provided | Uncertain significance (Oct 24, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780234
- GRCh38:
- Chr2:168923724
| ABCB11 | | not provided | Likely benign (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780244
- GRCh38:
- Chr2:168923734
| ABCB11 | I1285N | not provided | Uncertain significance (Jul 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780249
- GRCh38:
- Chr2:168923739
| ABCB11 | | not provided | Likely benign (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780250
- GRCh38:
- Chr2:168923740
| ABCB11 | A1283V | not provided, Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2
| Uncertain significance (May 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:169780252
- GRCh38:
- Chr2:168923742
| ABCB11 | | not provided | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780258
- GRCh38:
- Chr2:168923748
| ABCB11 | | not provided | Likely benign (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780264
- GRCh38:
- Chr2:168923754
| ABCB11 | | not provided | Likely benign (Apr 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780264
- GRCh38:
- Chr2:168923754
| ABCB11 | | not specified | Uncertain significance (Jun 27, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780270
- GRCh38:
- Chr2:168923760
| ABCB11 | | not provided | Likely benign (Jun 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780281
- GRCh38:
- Chr2:168923771
| ABCB11 | I1273V | not provided | Uncertain significance (Nov 16, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780286
- GRCh38:
- Chr2:168923776
| ABCB11 | I1271N | Progressive familial intrahepatic cholestasis type 2 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:169780288
- GRCh38:
- Chr2:168923778
| ABCB11 | | not provided | Likely benign (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780292
- GRCh38:
- Chr2:168923782
| ABCB11 | T1269I | Progressive familial intrahepatic cholestasis | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780294
- GRCh38:
- Chr2:168923784
| ABCB11 | | not provided | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780294
- GRCh38:
- Chr2:168923784
| ABCB11 | T1269fs | not provided | Pathogenic (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780296
- GRCh38:
- Chr2:168923786
| ABCB11 | | not provided | Likely benign (Nov 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780296
- GRCh38:
- Chr2:168923786
| ABCB11 | R1268W | not provided | Pathogenic (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780300
- GRCh38:
- Chr2:168923790
| ABCB11 | | not provided | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780311
- GRCh38:
- Chr2:168923801
| ABCB11 | K1263* | not provided | Pathogenic (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780312
- GRCh38:
- Chr2:168923802
| ABCB11 | | not provided | Likely benign (May 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780316
- GRCh38:
- Chr2:168923806
| ABCB11 | L1261P | not provided | Uncertain significance (Jan 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780320
- GRCh38:
- Chr2:168923810
| ABCB11 | A1260P | not provided | Uncertain significance (Nov 28, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780323
- GRCh38:
- Chr2:168923813
| ABCB11 | V1259I | not provided | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780326
- GRCh38:
- Chr2:168923816
| ABCB11 | Q1258* | not provided | Pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780327
- GRCh38:
- Chr2:168923817
| ABCB11 | | not provided | Likely benign (Sep 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780330
- GRCh38:
- Chr2:168923820
| ABCB11 | | not specified, not provided | Conflicting interpretations of pathogenicity (Dec 21, 2017) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:169780330-169780331
- GRCh38:
- Chr2:168923820-168923821
| ABCB11 | V1257fs | not provided | Pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780331
- GRCh38:
- Chr2:168923821
| ABCB11 | T1256R | not provided | Uncertain significance (May 2, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780336
- GRCh38:
- Chr2:168923826
| ABCB11 | | not provided | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780342
- GRCh38:
- Chr2:168923832
| ABCB11 | | not provided | Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:169780366
- GRCh38:
- Chr2:168923856
| ABCB11 | | not provided, Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2
| Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:169780885
- GRCh38:
- Chr2:168924375
| ABCB11 | | not provided | Benign (Nov 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169780961
- GRCh38:
- Chr2:168924451
| ABCB11 | | not provided | Benign (Nov 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781159
- GRCh38:
- Chr2:168924649
| ABCB11 | | not provided | Likely benign (Feb 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781197
- GRCh38:
- Chr2:168924687
| ABCB11 | | not provided | Likely benign (Feb 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781200
- GRCh38:
- Chr2:168924690
| ABCB11 | | not provided | Likely benign (Jun 28, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781204
- GRCh38:
- Chr2:168924694
| ABCB11 | D1243G | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781209
- GRCh38:
- Chr2:168924699
| ABCB11 | | not provided | Likely benign (Dec 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781210
- GRCh38:
- Chr2:168924700
| ABCB11 | L1241P | not provided | Likely pathogenic (Jan 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781226
- GRCh38:
- Chr2:168924716
| ABCB11 | D1236Y | not provided | Uncertain significance (Aug 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781229
- GRCh38:
- Chr2:168924719
| ABCB11 | R1235* | not provided | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781240
- GRCh38:
- Chr2:168924730
| ABCB11 | R1231Q | not provided | Pathogenic (Sep 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:169781241
- GRCh38:
- Chr2:168924731
| ABCB11 | R1231W | not provided, Familial intrahepatic cholestasis type 2 | Pathogenic/Likely pathogenic (May 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:169781245
- GRCh38:
- Chr2:168924735
| ABCB11 | I1229M | Progressive familial intrahepatic cholestasis type 2 | Uncertain significance (Dec 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781248
- GRCh38:
- Chr2:168924738
| ABCB11 | | not provided | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781255
- GRCh38:
- Chr2:168924745
| ABCB11 | R1226L | Cholestasis, intrahepatic, of pregnancy, 3 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:169781256
- GRCh38:
- Chr2:168924746
| ABCB11 | R1226C | not provided | Uncertain significance (Jul 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781263
- GRCh38:
- Chr2:168924753
| ABCB11 | | not provided | Likely benign (Nov 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781263
- GRCh38:
- Chr2:168924753
| ABCB11 | E1223D | Cholestasis, intrahepatic, of pregnancy, 3 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:169781270
- GRCh38:
- Chr2:168924760
| ABCB11 | R1221K | Progressive familial intrahepatic cholestasis type 2 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:169781272-169781273
- GRCh38:
- Chr2:168924762-168924763
| ABCB11 | | not provided | Pathogenic (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781285
- GRCh38:
- Chr2:168924775
| ABCB11 | G1216A | not provided | Uncertain significance (Jun 6, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781296
- GRCh38:
- Chr2:168924786
| ABCB11 | S1214fs | not provided | Pathogenic (Jul 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781298
- GRCh38:
- Chr2:168924788
| ABCB11 | V1212I | not provided | Uncertain significance (Mar 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781299
- GRCh38:
- Chr2:168924789
| ABCB11 | | Progressive familial intrahepatic cholestasis type 2, not provided | Conflicting interpretations of pathogenicity (Jun 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:169781301
- GRCh38:
- Chr2:168924791
| ABCB11 | N1211D | not provided | Likely benign (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781303
- GRCh38:
- Chr2:168924793
| ABCB11 | T1210S | not provided | Conflicting interpretations of pathogenicity (Jun 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:169781304
- GRCh38:
- Chr2:168924794
| ABCB11 | T1210P | not provided | Likely pathogenic (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781308
- GRCh38:
- Chr2:168924798
| ABCB11 | | not provided | Likely benign (Aug 17, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:169781316-169781317
- GRCh38:
- Chr2:168924806-168924807
| ABCB11 | | not provided | Benign (Mar 29, 2022) | criteria provided, single submitter |